Deaths attributed to both acute heart attack and obesity rose between 2007 and 2019, according to findings from the CDC ...

The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other ...

Queen Latifah opens up about obesity and heart health risks for public awareness campaign, Truth About Weight.

I worry about how these changes, which are occurring at the age of 13 or 14, might affect them later in life,” the study’s ...

A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their ...

Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule ...

A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...

Many are from the most deprived areas, and a significant number are neurodivergent or have other health conditions, a study ...

A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrates positive ...

Novo Nordisk is partnering with the biotech Septerna to develop oral obesity drugs, as it aims for more convenient weight ...

Currently trailing Eli Lilly and Structure Therapeutics in the oral weight loss space, Novo Nordisk strikes a deal with ...

The research collaboration, under which Septerna will receive more than $200 million in upfront and near-term fees, is the ...